FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based ...

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...

A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which has previously attempted to block Lumryz’s ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan ...

A potential three-year framework agreement between the Greek government and the pharmaceutical industry, starting at the ...

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enhance the development of next-generation RLTs.

In the US, diagnosed prevalence is anticipated to increase across all opioid addiction patient segments. Credit: Iryna Imago ...

With less than three weeks until Americans cast their vote, what would healthcare look under a Harris or Trump administration ...